Aveanna Healthcare Holdings Inc. (AVAH) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with raised guidance, successful integration of Thrive, and strategic growth in preferred payer agreements. Despite some headwinds, management shows confidence in achieving 2025 targets. The Q&A section reaffirms positive momentum in key business areas, with proactive measures to mitigate risks. The overall sentiment is positive, suggesting a likely stock price increase.
Key Financial Performance
Revenue Revenue for the third quarter was approximately $622 million, representing a 22.2% increase over the prior year period. The increase was primarily due to improved rate and volume environment and continued cost savings initiatives.
Adjusted EBITDA Third quarter adjusted EBITDA was $80.1 million, representing a 67.5% increase over the prior year period. This growth was driven by improved rate and volume environment and enhanced operational efficiencies.
Private Duty Services Revenue Revenue for the quarter was approximately $514 million, a 25.6% increase compared to the prior year. This was driven by approximately 11.8 million hours of care, a volume increase of 12.9%, and a revenue per hour of $43.51, up 12.7% from the prior year quarter. The growth was attributed to preferred payer volume growth and rate enhancements.
Home Health and Hospice Revenue Revenue for the quarter was approximately $62.4 million, a 15.3% increase over the prior year. This was driven by 9,700 total admissions (9% growth) and 12,900 total episodes of care (14.2% growth). Medicare revenue per episode was $3,215, up 3.6% from the prior year quarter. The growth was due to a focus on preferred payers reimbursing on an episodic basis.
Medical Solutions Revenue Revenue for the quarter was $45.1 million, essentially flat from the prior year period. Revenue was driven by approximately 91,000 unique patients served and revenue per unique patient served of approximately $495, up 0.6% over the prior year period.
Gross Margin Consolidated gross margin was $202.8 million or 32.6%. This reflects an improved rate environment, increased volumes, and enhanced operational efficiencies.
Liquidity Liquidity at the end of the third quarter was approximately $479 million, representing cash on hand of approximately $146 million, $106 million of availability under the securitization facility, and approximately $227 million of availability on the revolver.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Thrive Skilled Pediatrics integration: Integration efforts are on target to complete by the end of the year. The acquisition is accretive to 2025 results and has broadened the company's strategy into Kansas and New Mexico.
Preferred payer agreements: Added 5 new agreements in Q3, reaching a total of 30 agreements for private duty services. Preferred payer agreements now account for 56% of total PDS MCO volumes. In home health, 45 preferred payer agreements were maintained, with episodic mix at 77% and total episodic volume growth of 14.2%.
Market expansion: Thrive SPC acquisition expanded operations into Kansas and New Mexico.
Revenue growth: Q3 revenue was $622 million, a 22.2% increase over the prior year. Adjusted EBITDA grew by 67.5% to $80.1 million, driven by improved rates, volume environment, and cost-saving initiatives.
Private Duty Services: Revenue grew by 25.6% to $514 million, driven by a 12.9% increase in care hours and rate enhancements. Gross margin was 29%.
Home Health and Hospice: Revenue increased by 15.3% to $62.4 million, with a gross margin of 53.3%. Total admissions grew by 9% year-over-year.
Medical Solutions: Revenue was $45.1 million, flat year-over-year. Gross margin was 45%. Efforts are ongoing to align operations with preferred payers.
Strategic transformation: Focus on enhancing partnerships with government and preferred payers, identifying cost efficiencies, modernizing Medical Solutions, managing capital structure, and engaging employees.
Regulatory advocacy: Efforts to improve Medicaid reimbursement rates in 10 states and defend Medicare home health benefits. Advocacy for halting proposed cuts to home health services.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Labor Market Challenges: The labor environment remains a primary challenge for Aveanna, impacting its ability to resume growth. While there are improvements in caregiver hiring and retention trends, the company continues to face difficulties in attracting and retaining caregivers, which is critical for meeting market demand.
Regulatory and Legislative Risks: The company faces headwinds from state Medicaid directors and governors due to potential reductions in overall Medicaid funding. Additionally, there are significant concerns about proposed cuts to the Medicare home health benefit, which could adversely impact operations and financial outcomes.
Reimbursement Rate Challenges: Aveanna's ability to secure adequate reimbursement rates from payers and government partners is critical. While progress has been made, the company continues to advocate for rate improvements in multiple states, which remains a key focus area to ensure financial stability.
Integration Risks: The integration of Thrive Skilled Pediatrics, while progressing well, carries inherent risks of not achieving expected synergies or operational efficiencies, which could impact financial performance.
Economic and Funding Uncertainties: Potential economic uncertainties and funding challenges, particularly related to Medicaid and Medicare, could create financial pressures and impact the company's ability to deliver services effectively.
Preferred Payer Strategy Execution: While the preferred payer strategy has shown positive momentum, its full implementation across all business segments, including Medical Solutions, is still in progress. Delays or inefficiencies in execution could hinder financial and operational goals.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Preferred Payer Strategy: Aveanna aims to increase the number of private duty services preferred payer agreements from 22 to 30 in 2025. They have already achieved this goal in Q3 and are expanding this strategy to other segments like Medical Solutions, targeting full implementation by early 2026.
Legislative Advocacy: The company is advancing a legislative agenda to improve reimbursement rates in at least 10 states for 2025 and advocating for Medicaid rate integrity for children with complex medical conditions. Efforts are also underway to address potential Medicaid funding cuts and oppose proposed Medicare home health rule changes for 2026.
Thrive Skilled Pediatrics Integration: Integration of Thrive Skilled Pediatrics is on track to be completed by the end of 2025, with expected synergies and accretive results to the company's financials.
Strategic Plan for 2025: The company focuses on enhancing partnerships, identifying cost efficiencies, modernizing the Medical Solutions business, managing capital structure, and engaging employees to deliver on its mission.
Revenue and EBITDA Projections for 2025: Aveanna anticipates 2025 revenue to exceed $2.375 billion and adjusted EBITDA to surpass $300 million, reflecting a prudent view of regulatory challenges.
Private Duty Services Growth: The company expects normalized growth rates in all three business segments, supported by rate improvements and preferred payer agreements. Private Duty Services revenue per hour increased by 12.7% in Q3 2025.
Home Health and Hospice Growth: Episodic mix is expected to remain above 70%, with continued focus on preferred payers. Q3 2025 episodic volume growth was 14.2%, and total admissions grew by 9% year-over-year.
Medical Solutions Segment: The preferred payer strategy is being implemented, with gross margins expected to normalize in the 42%-44% range. Growth in unique patients served and revenue per patient is anticipated as the target operating model is achieved by early 2026.
Regulatory Environment: Advocacy efforts are focused on Medicaid and Medicare policies, with ongoing discussions to mitigate potential funding cuts and oppose Medicare home health rule changes for 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Every year, the fourth quarter EBITDA has been higher than the third quarter. Are there any headwinds for the fourth quarter, or is this just standard conservatism?
A:Management expects Q4 to be similar to Q3, with some holiday seasonality. They maintain a conservative approach, raising revenue guidance by at least $75 million and EBITDA by $30 million quarter-over-quarter. They highlighted their beat-and-raise mentality and the success of the Thrive acquisition.
Q:Can third quarter results be annualized as a launch pad for 2026 earnings, considering the preferred payer agreements?
A:Management is focused on finishing 2025 strong. They noted momentum in their PDS and HHH businesses and ongoing work in Med Solutions. They highlighted wage pass-throughs and rate wins but acknowledged headwinds in state Medicaid systems for 2026.
Q:In PDS, with rate increases translating into better hours, is this the right jumping-off point for 2026? What about the path to a 10 to 10.50 spread rate in PDS?
A:Management confirmed 11.8 million hours of care in Q3 as the basis for Q4, with some seasonality expected. They anticipate smaller rate wins in 2026 but are prepared for this. Gross margin for PDS settled at 29%, and wage pass-throughs will continue into 2026.
Q:How should we think about your views on capital structure and capital deployment towards acquisitions?
A:Management highlighted $86 million of free cash flow year-to-date and plans to continue generating free cash flow in 2026. They will thoughtfully deploy capital for M&A or debt repayment, depending on what makes the most sense.
Q:What is the market appetite for value-based care contracts in private duty nursing?
A:Management sees strong demand from payers for more nurses and capacity. They emphasized their upside-only value-based agreements and the positive feedback from payers, particularly after the Thrive acquisition.
Q:On home health hospice, with nice volume growth and episodic mix, is there anything notable on the expense side?
A:Management reported 15.3% growth in the division, with 77% of admissions as episodic. Gross margin was 53.3%, in line with expectations. They are investing in training but see no major concerns.
Q:How are census or patients served trending relative to hours per census yield?
A:Management stated that census and hours per census are directionally in line. They emphasized high demand for caregivers and their efforts to fill as many shifts as possible.
Q:On home health and hospice, how does reimbursement on episodic rates compare to fee-for-service?
A:Management stated there is no parity between episodic and fee-for-service rates, which is why they focus on episodic care. They aim to increase episodic care to 80% of their business.
Q:How have preferred payer relationships evolved over time?
A:Management noted improvements in collections, patient care, and value-based agreements. They highlighted the benefits of scale and technology in meeting payer needs.
Q:Are there areas where you are leaning into new opportunities or being cautious?
A:Management is focused on expanding Medicaid reach and skilled services. They aim to enter additional Medicaid states and leverage their Medicaid book to grow home health and hospice.
Q:What is the contribution of Thrive in the quarter, and what is its annualized earnings contribution?
A:Thrive contributed significantly to Q3 results, with $100 million in revenue and a 7.5x purchase price multiple. Integration is nearly complete, and Thrive has been a strong addition.
Q:Are comments on state budget uncertainty more directional or based on specific actions?
A:Comments are more directional, reflecting general uncertainty and headwinds in state Medicaid systems. Some states have implemented temporary rate reductions to balance budgets.
Q:What is the sustainability of growth in preferred payer relationships?
A:Management sees a long runway for growth, with plans to increase preferred payer volumes and expand into new markets. They aim to align capacity with payer needs.
Q:What are your intermediate leverage targets, and how will you achieve them?
A:Management aims for a leverage ratio with a '3 handle' in the next few years, achieved through EBITDA growth and thoughtful capital deployment.
Q:Has uncertainty in home health reimbursement impacted the pipeline of opportunities?
A:Management has been cautious with home health and hospice acquisitions, awaiting clarity on the final rule. They expect the rule to be neutral and are prepared to act once there is certainty.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the question about annualizing third-quarter results for 2026 earnings, focusing instead on finishing 2025 strong. They also provided limited detail on the path to achieving a 10 to 10.50 spread rate in PDS, emphasizing general preparedness and smaller rate wins.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
America plan
CMS impact
Democrat CMS
Medicaid future
Medical Solutions
Medicare update
Mexico payer
OBBBA legislation
PDM cut
Pediatrics integration
Skill Pediatrics
Solutions date
State legislator
Thrive Skill
acquisition momentum
acquisition state
advocacy
agenda effort
agreement payer
calendar disappointment
calendar rule
child duty
comment letter
conversation leader
customer experience
day result
disappointment significance
effort focus
effort goal
end job
health rule
improvement outcome
payer Medical
senior
service payer
state Medicaid
AVAH Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call Transcript
Unknown5-14
The earnings call presents a mixed picture: revenue and adjusted EBITDA grew modestly, but net income fell due to increased expenses. Operational updates and strategic initiatives were not discussed, limiting insight into future growth. Risk factors were highlighted, but no new partnerships or guidance changes were announced. With no major catalysts or negative surprises, the stock price is likely to remain stable, leading to a neutral sentiment.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Positive3-19
The earnings call indicates strong cash collections and cost efficiency, contributing to a positive free cash flow. The Family First acquisition is expected to be accretive and minimally impact leverage. Positive growth outlooks across business segments and AI initiatives further enhance sentiment. While some uncertainties exist, such as California's home-based nursing rates, the overall sentiment is positive due to strong financial performance and strategic growth plans.
Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-14
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Bank of America Home Care Conference Transcript
Neutral12-9
AVAH Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
